Joseph Tamara L's Form 4 filing
Spero Therapeutics, Inc. (SPRO) · filed Feb 3, 2023
- Accession no.
- 0000899243-23-003946
- Filed
- Feb 3, 2023
- Trade date
- Feb 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.31K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Joseph Tamara LCIK 0001433991 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | AGrant or awardAcquired | +265,957 | $0.00 | $0 | 328,038 | Direct | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −3,394 | $1.86 | −$6,312.84 | 324,644 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.